Indian Billionaire's Vaccine Maker Hunts for AcquisitionsBy
Head of Asia’s largest vaccine maker expects consolidation
Could sell stake in his firm and debt to buy smaller rivals
The chief executive officer of Asia’s largest vaccine maker said he will consider selling a stake to private equity investors as he hunts for acquisitions in preparation for a bout of consolidation to hit the industry over the next few years.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.